Activate your complimentary access to the Science family of journals
In coordination with MOBIUS, AAAS is pleased to present an offer for the Science family of journals. In order to assist in your decision making, AAAS would like to provide your organization short-term and complimentary access to the Science family of journals. This complimentary access includes Science Signaling, Science Translational Medicine, Science Immunology, and Science Robotics and will last from October 6th to December 15th.
Getting to know the Science family of journals
The Science family of journals includes Science, Science Signaling, Science Translational Medicine, Science Immunology, and Science Robotics. Below is brief information about each of the journals, including the purpose for each journal, the subjects covered, and the typical readers.
Overview
Scope and Audience
Because of its broad scope and mix of content types, Science is appropriate for members of the general public and students who wish to better understand news, policy, and scientific research, as well as for scientists seeking to learn about groundbreaking research.
Overview
Scope and Audience
Science Signaling is appropriate for organizations that support the research and study of biochemistry, cellular and molecular biology, immunology, neuroscience, pharmacology, physiology and medicine, and plant biology.
Topics covered include molecular mechanisms of signaling and regulation within cells and the mechanisms by which cells and organisms communicate and affect each other’s behavior, signaling relevant to human physiology and disease and to plant physiology that is important for agriculture, and signaling between animals or plants and their commensal microbes and pathogens.
Overview
Science Translational Medicine publishes research that translates research from the lab into medical practice impacting patient care and in turn, translates medical practice back to lab scientists. Articles published in Science Translational Medicine focus on the emergence of personalized diagnosis and treatment to improve patient care worldwide.
Scope and Audience
Science Translational Medicine is appropriate for researchers and management in academia, government, and the biotechnology and pharmaceutical industries; physician scientists; regulators; policy makers; investors; business developers; and funding agencies.
Topics covered include bioengineering cancer, cardiovascular disease, diabetes and other metabolic diseases, drug development and delivery, genomic medicine, infectious diseases, immunology and vaccines, bioengineering, pharmacokinetics, neurology, psychiatry, medical informatics, and regenerative medicine.
Overview
Scope and Audience
Science Immunology is appropriate for organizations that support the research and study of cell biology, immunology, transplantation, and infectious diseases.
Topics covered include Host defense, Inflammation, Cancer immunology, Autoimmunity, Allergy, Immunodeficiency, Immunogenomics, Systems immunology, Structural immunology, Antigen presentation, Immunometabolism and Mucosal immunology.
Overview
Scope and Audience
Science Robotics is appropriate for organizations that support the research and study of robotics, mechanical engineering, biomechanics, civil engineering, electrical engineering, artificial intelligence, human computer interaction (HCI), and ethics.
Topics covered include micro/nano robots, land and undersea robots, medical and surgical robots, space robots, marine and agricultural robots, artificial intelligence, biomaterials, biorobotics, and theoretical advances in robotics.
Getting Started
For questions about the MOBIUS package or for additional information about any of the Science family of journals, please contact Ryan Rexroth.
To activate your complimentary access, please provide the information below. Your access will be from October 6th to December 15th.